The Weight-Loss Drug Frenzy Is Outrunning The Company Novo Nordisk A/S Behind It

Injection pen parts at the Novo Nordisk A/S production facilities in Hillerod, Denmark, on Monday, June 12, 2023. The success of Novo's bestsellers Ozempic and Wegovy, drugs that help people lose significant amounts of weight, has created something of a gold rush in the pharma industry with about 40 companies developing products that will intensify competition. Photographer: Carsten Snejbjerg/Bloomberg via Getty Images
Injection pen parts at the Novo Nordisk A/S production facilities in Hillerod, Denmark, on Monday, June 12, 2023. The success of Novo's bestsellers Ozempic and Wegovy, drugs that help people lose significant amounts of weight, has created something of a gold rush in the pharma industry with about 40 companies developing products that will intensify competition. Photographer: Carsten Snejbjerg/Bloomberg via Getty Images
The Weight-Loss Drug Frenzy Is Outrunning The Company Novo Nordisk A/S Behind It
PURCHASE A LICENSE
How can I use this image?
$375.00
USD
Getty ImagesThe Weight-Loss Drug Frenzy Is Outrunning The Company Novo Nordisk..., News PhotoThe Weight-Loss Drug Frenzy Is Outrunning The Company Novo Nordisk..., News PhotoThe Weight-Loss Drug Frenzy Is Outrunning The Company Novo Nordisk... Get premium, high resolution news photos at Getty ImagesProduct #:1586472129
$499$175
Getty Images
In stock

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
1586472129
Collection:
Bloomberg
Date created:
June 12, 2023
Upload date:
License type:
Rights-managed
Release info:
Not released. More information
Source:
Bloomberg
Object name:
DENMARK NOVO
Max file size:
8192 x 5462 px (27.31 x 18.21 in) - 300 dpi - 38 MB